Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

July 31, 2014

Harvard Bio sees slight increase in revenue, earnings

Harvard Bioscience said a focus on its global growth strategy and a weaker dollar compared to the British pound and the Euro helped boost revenue slightly, as the life sciences manufacturer brought in $27 million, up 3 percent from $26.1 million in the second quarter of 2013.

Meanwhile, the Holliston-based firm said income from continuing operations was $1 million, or 3 cents per share, up slightly from the same period a year ago.

Harvard Bio said its previous outlook that 2014 would be a “bridge year” to better growth in 2015 stands, as it remains “encouraged” by second-quarter bookings and backlogs.

Bookings for the quarter amounted to $27.4 million, compared with $25.8 million in the second quarter of 2013. Harvard Bio’s backlog at the end of the quarter was $6 million, compared with $5.6 million in the first quarter and $3.8 million in the second quarter of 2013, it said.

Sign up for Enews

WBJ Web Partners

0 Comments

No More articles left

To read more, please
Login or Register (free)

 

To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy

Allow Cookies